Javascript must be enabled to continue!
Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts
View through CrossRef
Formation of intrahepatic bile ducts (IHBDs) proceeds in accordance with their microenvironment. Particularly, mesenchymal cells around portal veins regulate the differentiation and ductular morphogenesis of cholangiocytes in the developing liver; however, further studies are needed to fully understand the arrangement of IHBDs into a continuous hierarchical network. This study aims to clarify the interaction between biliary and liver mesenchymal cells during IHBD formation. To identify candidate factors contributing to this cell–cell interaction, mesenchymal cells were isolated from embryonic day 16.5 matrix metalloproteinase 14 (MMP14)‐deficient (knockout [KO]) mice livers, in which IHBD formation is retarded, and compared with those of the wild type (WT). WT mesenchymal cells significantly facilitated the formation of luminal structures comprised of hepatoblast‐derived cholangiocytes (cholangiocytic cysts), whereas MMP14‐KO mesenchymal cells failed to promote cyst formation. Comprehensive analysis revealed that expression of vasoactive intestinal peptide (VIP) was significantly suppressed in MMP14‐KO mesenchymal cells. VIP and VIP receptor 1 (VIPR1) were mainly expressed in periportal mesenchymal cells and cholangiocytic progenitors during IHBD development, respectively, in vivo. VIP/VIPR1 signaling significantly encouraged cholangiocytic cyst formation and up‐regulated tight junction protein 1, cystic fibrosis transmembrane conductance regulator, and aquaporin 1, in vitro. VIP antagonist significantly suppressed the tight junction assembly and the up‐regulation of ion/water transporters during IHBD development in vivo. In a cholestatic injury model of adult mice, exogenous VIP administration promoted the restoration of damaged tight junctions in bile ducts and improved hyperbilirubinemia. Conclusion: VIP is produced by periportal mesenchymal cells during the perinatal stage. It supports bile duct development by establishing tight junctions and up‐regulating ion/water transporters in cholangiocytes. VIP contributes to prompt recovery from cholestatic damage through the establishment of tight junctions in the bile ducts.
Ovid Technologies (Wolters Kluwer Health)
Ayako Sato
Sei Kakinuma
Masato Miyoshi
Akihide Kamiya
Tomoyuki Tsunoda
Shun Kaneko
Jun Tsuchiya
Taro Shimizu
Eiko Takeichi
Sayuri Nitta
Fukiko Kawai‐Kitahata
Miyako Murakawa
Yasuhiro Itsui
Mina Nakagawa
Seishin Azuma
Naohiko Koshikawa
Motoharu Seiki
Hiromitsu Nakauchi
Yasuhiro Asahina
Mamoru Watanabe
Title: Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts
Description:
Formation of intrahepatic bile ducts (IHBDs) proceeds in accordance with their microenvironment.
Particularly, mesenchymal cells around portal veins regulate the differentiation and ductular morphogenesis of cholangiocytes in the developing liver; however, further studies are needed to fully understand the arrangement of IHBDs into a continuous hierarchical network.
This study aims to clarify the interaction between biliary and liver mesenchymal cells during IHBD formation.
To identify candidate factors contributing to this cell–cell interaction, mesenchymal cells were isolated from embryonic day 16.
5 matrix metalloproteinase 14 (MMP14)‐deficient (knockout [KO]) mice livers, in which IHBD formation is retarded, and compared with those of the wild type (WT).
WT mesenchymal cells significantly facilitated the formation of luminal structures comprised of hepatoblast‐derived cholangiocytes (cholangiocytic cysts), whereas MMP14‐KO mesenchymal cells failed to promote cyst formation.
Comprehensive analysis revealed that expression of vasoactive intestinal peptide (VIP) was significantly suppressed in MMP14‐KO mesenchymal cells.
VIP and VIP receptor 1 (VIPR1) were mainly expressed in periportal mesenchymal cells and cholangiocytic progenitors during IHBD development, respectively, in vivo.
VIP/VIPR1 signaling significantly encouraged cholangiocytic cyst formation and up‐regulated tight junction protein 1, cystic fibrosis transmembrane conductance regulator, and aquaporin 1, in vitro.
VIP antagonist significantly suppressed the tight junction assembly and the up‐regulation of ion/water transporters during IHBD development in vivo.
In a cholestatic injury model of adult mice, exogenous VIP administration promoted the restoration of damaged tight junctions in bile ducts and improved hyperbilirubinemia.
Conclusion: VIP is produced by periportal mesenchymal cells during the perinatal stage.
It supports bile duct development by establishing tight junctions and up‐regulating ion/water transporters in cholangiocytes.
VIP contributes to prompt recovery from cholestatic damage through the establishment of tight junctions in the bile ducts.
Related Results
Predictive value of random sample urine bile acids corrected by creatinine in liver disease
Predictive value of random sample urine bile acids corrected by creatinine in liver disease
Bile acids, in a random sample of urine, discriminated normal controls from liver disease, with a probability similar to fasting plasma bile acids (p < 0.01 and p < 0.001, de...
Innervation of interstitial cells of Cajal by vasoactive intestinal polypeptide containing nerves in canine colon
Innervation of interstitial cells of Cajal by vasoactive intestinal polypeptide containing nerves in canine colon
The hypothesis was tested, through structural and functional studies, that interstitial cells of Cajal receive and can respond to direct innervation from nerves containing the vaso...
The Mutant Eisai Hyperbilirubinemic Rat Is Resistant to Bile Acid-Induced Cholestasis and Cytotoxicity
The Mutant Eisai Hyperbilirubinemic Rat Is Resistant to Bile Acid-Induced Cholestasis and Cytotoxicity
We investigated bile flow and biliary excretion of bile acids in the Eisai hyperbilirubinemic rat, a Sprague–Dawley mutant rat with conjugated hyperbilirubinemia, using both
...
Differential marker expression by cultures rich in mesenchymal stem cells
Differential marker expression by cultures rich in mesenchymal stem cells
AbstractBackgroundMesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires...
АNALYSIS OF THE STRUCTURE OF THE INTRAHEPATIC BILE DUCTS OF MAMMALS WITH A MIXED TYPE OF NUTRITION
АNALYSIS OF THE STRUCTURE OF THE INTRAHEPATIC BILE DUCTS OF MAMMALS WITH A MIXED TYPE OF NUTRITION
Diseases of the biliary system, such as cholecystitis of various etiologies, gallstone disease, post-cholecystectomy syndrome and cholangitis, are becoming more common. Every tenth...
Isolated cystic duct cyst in a child :A case report
Isolated cystic duct cyst in a child :A case report
Abstract
Background:
Dilatation of the common bile duct is a common biliary malformation in children. However, isolated cysts of the cystic duct are extremely rare and not ...
ZO‐2 Protein But Not ZO‐1 Protein Limits Occludin Lateral Mobility in MDCK Type II Renal Epithelial Cells
ZO‐2 Protein But Not ZO‐1 Protein Limits Occludin Lateral Mobility in MDCK Type II Renal Epithelial Cells
The tight junction‐associated Zonula Occludens proteins, ZO‐1 and ZO‐2, possess binding sites for multiple tight junction membrane proteins, including occludin, multiple tight junc...

